Trial Radar
Sign in

NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Continuing Access to Axitinib (A406- AG- 013736 ) For Patients Previously Receiving AG 013736 In Clinical Trials
Continuing Access to Axitinib (A406- AG- 013736 ) For Patients Previously Receiving AG 013736 In Clinical Trials

NCT00828919

CompletedNA

Sponsor: Pfizer

Conditions: Solid Tumors

Interventions: axitinib, crizotinib

Countries: United States, Czechia, France, Germany, Hungary, Italy, Japan, Russia

To allow continuation of axitinib (AG 013736) treatment to patients experiencing clinical benefit in a closing axitinib trial

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria
Inclusion Criteria:

* Patients who were assigned to an axitinib (AG-013736) containing treatment arm in a previous clinical trial
* Patients who were receiving axitinib (AG-013736) tablets at the time their previous trial ended
* Patients who have stable (SD) or responding disease (PR or CR) documented by the appropriate radiological, clinical, or laboratory assessments within 12 weeks before enrollment (Note: response criteria from the previous axitinib (AG-013736) protocol should be used to determine stable or responding disease).
* Patients who have progressive disease (PD) but have experienced "clinical benefit" as defined in the study protocol

Exclusion Criteria:

* Patients may not participate in this trial if the conditions for continuing treatment in the previous axitinib (AG-013736) protocol are not met
Locations (34)
  • Orange, California, United States
  • Orange, California, United States
  • San Francisco, California, United States
  • Santa Monica, California, United States
  • Chicago, Illinois, United States
  • Baltimore, Maryland, United States
  • Baltimore, Maryland, United States
  • Ann Arbor, Michigan, United States
  • New York, New York, United States
  • New York, New York, United States
  • New York, New York, United States
  • Cleveland, Ohio, United States
  • Philadelphia, Pennsylvania, United States
  • Houston, Texas, United States
  • Houston, Texas, United States
  • Everett, Washington, United States
  • Everett, Washington, United States
  • Madison, Wisconsin, United States
  • Olomouc, Czech Republic, Czechia
  • Prague, Czechia
  • Paris, France
  • Berlin, Germany
  • Budapest, Hungary
  • Milan, Italy
  • Milan, Italy
  • Kashiwa, Chiba, Japan
  • Sayama, Osaka, Japan
  • Chiba, Japan
  • Fukuoka, Japan
  • Nagasaki, Japan
  • + 4 more on CT.gov